Nezam El-Tayebat Fact CheckA scientific assessment of the “نظام الطيبات” nutrition system
Choose country
Choose language: English

Mostly false Overinterpreted Certainty of evidence: moderate provisional C-GRN-01

'There is no such thing as gluten sensitivity'; the real problem is only that white flour turns into a glue-like substance.

Safety note: People with diagnosed coeliac disease must maintain a strict lifelong gluten-free diet; ignoring the diagnosis can lead to anaemia, osteoporosis, infertility problems and, rarely, lymphoma.
In short: This claim is mostly false. Coeliac disease is a proven gluten-driven immune disease affecting about 1% of people, including in Egypt; only the narrower point that most self-diagnosed non-coeliac gluten sensitivity is not caused by gluten itself is supported by blinded trials.
Conclusion: Coeliac disease is real and gluten-driven; only the vaguer 'non-coeliac gluten sensitivity' is genuinely disputed.
  1. Original statement
  2. Scientific assessment
  3. Scientific evidence in detail
  4. In plain language
  5. Studies on this claim
  6. Regional context
  7. What applies in my country?
  8. References

Original statement

يبقى معنى كده ان كلمه الجلوتين حساسيه الجلوتين دي مش موجوده اصلا ما فيش حاجه اسمها حساسيه الجلوتين في حاجه اسمها دقيق ابيض ضرني ضيق ابيض اتحول لماده غرويه فضرني

verbatim according to source. Translation by the project; the Arabic wording is authoritative.

Translation

'There is no such thing as gluten sensitivity'; the real problem is only that white flour turns into a glue-like substance.

Origin

Source status
Video transcript (own words)
Attribution
Elawady (machine transcript)
Video
بدأت قناة ＂Dr Diaa Al Awady د ضياء العوضي＂ بثًا مباشرًاFAQs (Open source)
Published
6 April 2026
Timestamp
1:35:31 (location in the original video’s automatic YouTube caption track; confirms where the words occur, not who speaks)
Attribution uncertainty
Archive transcript (YouTube CC or AI-generated); wording may contain transcription errors; no timestamps available.
Claimed mechanism

Gluten is a normal nutrient; refined flour concentrates gluten and becomes colloidal.

Claimed health effect

Denial of gluten-related disorders.

Population concerned

Everyone, implicitly including people diagnosed with 'gluten allergy/sensitivity'.

Geographic restriction by Elawady

none found

Diverging source versions

Source status
Video transcript (own words)
Attribution
Elawady (machine transcript)
Video
ودي الحلقه التانيه من البودكاست…حلقه استثنائيه وقولولي رأيكوا (Open source)
Published
10 April 2026
Timestamp
not available (transcript has no timings)
Attribution uncertainty
Podcast; machine transcript: 'ما فيش حاجه اسمها جلوتن سنسيفيتي'.
Source status
Video transcript (own words)
Attribution
Elawady (machine transcript)
Video
مشكلة الدقيق مش جلوتين (Open source)
Published
28 January 2025
Timestamp
not available (transcript has no timings)
Attribution uncertainty
Archive transcript (YouTube CC or AI-generated); wording may contain transcription errors; no timestamps available.

Scientific assessment

Mostly false – Essential parts of the statement are not supported by the evidence or are strongly exaggerated.

Certainty of evidence: moderate – Further research may still affect the assessment.

1. What was claimed?

Gluten sensitivity does not exist.

2. What is demonstrably correct?

Many people who self-diagnose gluten sensitivity do not react to gluten under blinded conditions; fructans in wheat can cause symptoms (I-GRN-01). A large cohort found long-term gluten intake not associated with coronary heart disease in people without coeliac disease (I-WHT-07), but that study did not examine gluten sensitivity and itself describes non-coeliac gluten sensitivity as a clinical entity.

3. What is wrong or exaggerated?

Coeliac disease exists, is common (~1%), and requires strict gluten avoidance; denying 'gluten sensitivity' wholesale risks misleading coeliac patients.

4. What remains unclear?

The nature and prevalence of non-coeliac gluten/wheat sensitivity.

5. Which studies support it?

I-GRN-01, I-GRN-101 (only 16% of suspected NCGS confirmed in blinded challenges), I-GRN-102 (symptoms driven by expectancy), I-WHT-122 (NCGS symptoms not gluten-specific) - all only for non-coeliac sensitivity. I-WHT-07 supports only the narrower point that gluten is not a coronary risk for most people.

6. Which studies contradict it?

I-WHT-04, I-GRN-104 (coeliac disease in 0.53% of Egyptian children), I-GRN-02, I-GRN-105, I-GRN-106 (guidelines), I-GRN-103 (objective immune and epithelial markers in a subset of wheat-sensitive people).

7. What applies to Germany and Europe?

ESsCD guideline (I-GRN-02) recognises coeliac disease, dermatitis herpetiformis, and (less well-defined) NCGS.

8. What is known about Egypt?

Coeliac disease occurs in Egypt: about 1 in 187 children in a general-population screening, and 4.7-6.4% in children with diarrhoea or type 1 diabetes (I-GRN-104).

9. What practical conclusion is appropriate?

People diagnosed with coeliac disease must keep a strict gluten-free diet regardless of this statement.

Assessment details

Rationale for certainty of evidence

Coeliac disease is an established gluten-driven autoimmune disease (about 0.7-1.4% of people, I-WHT-04; guideline I-GRN-02). In Egyptian colloquial use 'حساسية الجلوتين' often refers to coeliac disease, so the statement as spoken denies a real disease. Partly correct: non-coeliac gluten sensitivity is poorly defined, and in a blinded crossover trial fructans rather than gluten induced symptoms (I-GRN-01).

Source quality

Live-stream statements.

Regional transferability

Universal.

Individual exceptions

Coeliac disease, wheat allergy and dermatitis herpetiformis are real gluten/wheat-related conditions.

Regional scope of the claim
general (biological/medical)
Last reviewed
26 October 2026 provisional

Scientific evidence in detail

Overinterpreted – A real finding exists, but the claim draws more from it than the data allow (e.g. association taken as cause, animal data applied to humans, small effect presented as large).

Research question: Do gluten-related disorders (coeliac disease, and non-coeliac gluten sensitivity) exist, and is the problem with wheat only a physical "glue" effect of white flour?

Research question in detail (PECO)
Population
General population including people diagnosed with coeliac disease or self-reported gluten sensitivity (Egypt and worldwide)
Intervention or exposure
Dietary gluten
Comparison
Gluten-free diet or placebo (blinded challenge)
Geographic scope
universal biology; Egypt-specific prevalence data checked
Outcomes
  • Biopsy/serology-confirmed coeliac disease
  • Gluten-specific symptoms in blinded challenge
  • Objective markers of intestinal damage

Study results as reported by the authors. Our assessment follows below.

What speaks for the claim?

What speaks against the claim?

  • How common is coeliac disease?

    Singh P et al.. Clin Gastroenterol Hepatol 2018 · PMID 29551598 · DOI 10.1016/j.cgh.2017.06.037 Meta-analysisabstract checked

    Global meta-analysis: coeliac disease, a gluten-driven immune enteropathy, affects about 1% of people.

    Actual result
    Seroprevalence 1.4% (1.1-1.7%); biopsy-confirmed 0.7% (0.5-0.9%).
    Methodological quality
    high (large meta-analysis)
    Relevance
    direct
    Limitations
    Heterogeneous screening methods.

    Original publication

  • Coeliac disease affects about 1 in 190 Egyptian children

    Abu-Zekry M et al.. J Pediatr Gastroenterol Nutr 2008 · PMID 18664863 · DOI 10.1097/MPG.0b013e31815ce5d1 Cross-sectional studyabstract checkednewly added

    Egyptian screening: coeliac disease in about 1 in 190 children of the general population and far more in risk groups.

    Actual result
    8/1500 = 0.53% (0.17-0.89); 4.7% with diarrhoea/failure to thrive; 6.4% in type 1 diabetes.
    Methodological quality
    moderate (biopsy-confirmed screening)
    Relevance
    direct and regional
    Limitations
    Single study, children only.

    Original publication

  • European guideline for coeliac disease

    Al-Toma A et al.. United European Gastroenterol J 2019 · PMID 31210940 · DOI 10.1177/2050640619844125 Guideline / position statementfull text, structured risk-of-bias assessment

    ESsCD guideline: coeliac disease and dermatitis herpetiformis are gluten-driven; lifelong strict gluten-free diet (strong, high evidence).

    Actual result
    Guideline recommendations (full text read).
    Methodological quality
    high (GRADE-based guideline)
    Relevance
    direct
    Limitations
    None relevant.

    Original publication

What does the overall evidence say?

Editorial assessment based on the studies above – not itself a study result.

Which position is better supported?

Coeliac disease is a real, common, gluten-driven disease; the sweeping statement "there is no such thing as gluten sensitivity" is wrong. The narrower point that most self-diagnosed non-coeliac gluten sensitivity is not gluten-specific is well supported.

Why some studies weigh more

Biopsy-confirmed prevalence data and GRADE-based guidelines carry most weight for coeliac disease; blinded RCTs carry most weight for NCGS. Single biomarker studies (I-GRN-103) weigh less.

Is a causal relationship established? Yes, established Gluten causes coeliac disease in genetically susceptible people (challenge, withdrawal and immunology evidence). For NCGS a gluten-specific causal role is not established for most patients.

Remaining uncertainty

Nature and prevalence of non-coeliac wheat sensitivity; role of fructans, amylase-trypsin inhibitors and nocebo.

Justified conclusion

Gluten-related disorders exist; only the vaguer non-coeliac gluten sensitivity is genuinely disputed.

Why do studies seem to disagree?

Blinded challenges (I-GRN-101, I-GRN-102, I-WHT-122) and the biomarker study (I-GRN-103) answer different questions: the trials test gluten-specific symptoms in self-diagnosed people; the biomarker study describes a subset with objective changes after wheat (not gluten alone). Neither concerns coeliac disease, which is established independently.

Does this depend on the country?
General biological effects
Coeliac disease biology is universal (HLA-DQ2/DQ8, tTG autoimmunity).
Eating habits
Wheat bread is a major staple in Egypt, so gluten exposure is high.
Origin of the food
Not relevant.
Contaminants
Not relevant.
National production conditions
Not relevant.
Legal rules
EU/Codex 20 ppm gluten-free standard.
Actual monitoring data
Egyptian screening data: 0.53% of children (I-GRN-104).

A regional difference that changes the conclusion is not supported by robust data.

Statistical re-check
  • Recalculate prevalence and CI – 8/1500 = 0.53%; Wald CI reproduces the reported 0.17-0.89%; Wilson CI 0.27-1.05%. recalculated
  • Recompute between-group differences from group means – Differences reproduce the reported values within 0.1 mm rounding; gluten without expectancy -0.5 mm. recalculated
  • Proportion check – 38/231 = 16.5% (reported 16%). recalculated
Certainty of the overall evidence (GRADE, simplified)
Main outcome
Existence and frequency of gluten-driven disease (coeliac disease)
Starting level
high (randomised trials)
Result
high

Simplified assessment by a single reviewer, following the GRADE approach; not a formal GRADE panel. GRADE rates the body of evidence for one outcome, not individual studies.

Clinical guidelines and official statements checked
  • ESsCD (European Society for the Study of Coeliac Disease): ESsCD guideline for coeliac disease and other gluten-related disorders (Al-Toma et al., UEG J 2019; study I-GRN-02) (2019) · Original publication
    Diagnostic testing (serology and biopsy) should be performed on a gluten-containing diet; a gluten-free diet should be introduced only when diagnosis is conclusive (strong, high); patients with coeliac disease should adhere to a lifelong gluten-free diet (strong, high); gluten-containing cereals are wheat, barley and rye; maize and oats are naturally gluten-free but can be contaminated; uncontaminated oats are tolerated by most patients; foods labelled gluten-free must contain <=20 ppm (EC 41/2009); NCGS is considered only after coeliac disease and wheat allergy are excluded on a gluten-containing diet; patients advised to eat whole-grain rice, maize, potatoes and vegetables.
  • American College of Gastroenterology: ACG Guidelines Update: Diagnosis and Management of Celiac Disease (Rubio-Tapia et al., Am J Gastroenterol 2023; I-GRN-105) (2023) · Original publication
    Abstract only (publisher full text blocked): coeliac disease is a permanent immune-mediated response to gluten in wheat, barley and rye; tTG antibodies for screening; biopsy required in most patients; treatment requires strict gluten-free diet and lifelong medical follow-up.
  • NICE (UK): Coeliac disease: recognition, assessment and management (NG20), Recommendations (2015) · Original publication
    Offer serological testing for unexplained GI symptoms, fatigue, weight loss, unexplained iron/B12/folate deficiency, IBS in adults, type 1 diabetes, first-degree relatives; tests are accurate only on a gluten-containing diet; do not start a gluten-free diet until a specialist confirms the diagnosis; eat gluten in more than one meal daily for at least 6 weeks before testing; gluten-free oats can be included.
Search strategy

Documented literature searches for this review (search strings in the original database syntax).

DatabaseDateSearchLooking forHitsIncluded
Europe PMC26 October 2026("non-celiac gluten sensitivity" OR "non-coeliac gluten sensitivity") AND (placebo OR nocebo OR "double-blind") AND (PUB_TYPE:"Meta-Analysis" OR PUB_TYPE:"Systematic Review" OR PUB_TYPE:"Randomized Controlled Trial")supporting evidence56
PubMed26 October 2026(non-celiac gluten sensitivity[tiab] OR nonceliac gluten sensitivity[tiab]) AND (double-blind[tiab] OR nocebo[tiab]) AND (meta-analysis[pt] OR systematic review[pt] OR randomized controlled trial[pt])supporting evidence12
PubMed26 October 2026(nonceliac[tiab] OR non-celiac[tiab] OR non-coeliac[tiab]) AND gluten[tiab] AND challenge[tiab] AND (meta-analysis[pt] OR systematic review[pt] OR meta-analysis[ti] OR systematic review[ti])supporting evidence2
PubMed26 October 2026Suspected nonceliac gluten sensitivity confirmed in few patients[ti]supporting evidence1
PubMed26 October 2026(gluten[ti] OR gliadin[ti]) AND (intestinal permeability[tiab] OR gut permeability[tiab] OR barrier[tiab]) AND (healthy[tiab]) AND (randomized[tiab] OR crossover[tiab] OR explant*[tiab] OR biopsy[tiab])both directions7
Europe PMC26 October 2026("wheat sensitivity" OR "gluten sensitivity") AND ("immune activation" OR "intestinal cell damage" OR "epithelial" ) AND (celiac OR coeliac) AND NOT PUB_TYPE:"Review"contradicting evidence707
PubMed26 October 2026Uhde M[au] AND wheat[ti] AND absence of coeliac disease[ti]contradicting evidence1
PubMed26 October 2026(celiac disease[tiab] OR coeliac disease[tiab]) AND (Egypt[tiab] OR Egyptian[tiab] OR Middle East[tiab] OR Arab[tiab]) AND prevalence[tiab]contradicting evidence50
Europe PMC26 October 2026(celiac OR coeliac) AND (Egypt OR Egyptian) AND (prevalence OR screening OR seroprevalence) AND (children OR adults)contradicting evidence1340
PubMed26 October 2026(celiac[ti] OR coeliac[ti]) AND (Egypt[ti] OR Egyptian[ti])contradicting evidence6
PubMed26 October 2026(celiac disease[ti]) AND (guideline[ti] OR guidelines[ti]) AND 2020:2026[dp]guidelines21

Open questions

Adult coeliac prevalence and diagnosis rates in Egypt.

How deeply was this checked?

11 linked studies: 3 checked in full text (2 of them with a structured risk-of-bias assessment), 8 on the basis of the abstract, 0 bibliographically only. No formal assessment with two independent reviewers and no independent human expert review has taken place yet.

Last scientific review: 26 October 2026

History of the verdict
  1. 25 October 2026 · Phase 1 · Initial assessment: Mostly false (moderate)
  2. 26 October 2026 · Phase 4 (systematic evidence review) · Re-examined with extended evidence; verdict unchanged: Mostly false (moderate)
    Unchanged. New blinded trials (I-GRN-101, I-GRN-102, I-WHT-122) strengthen the part of the claim about non-coeliac sensitivity; new Egyptian data (I-GRN-104) and the ACG/NICE guidelines strengthen the contradiction for coeliac disease. The balance and the moderate certainty (reflecting ambiguity of what the speaker meant by "gluten sensitivity") stay the same.
    New sources: I-GRN-101 I-GRN-102 I-GRN-103 I-GRN-104 I-GRN-105 I-GRN-106 I-WHT-122

In plain language

Dr. Diaa said in a live stream that gluten sensitivity does not exist. That is wrong for coeliac disease, an immune disease triggered by gluten that affects about one in a hundred people. He is partly right that many people who think they react to gluten actually react to other parts of wheat or not at all. People with coeliac disease must keep avoiding gluten.

Studies on this claim

Studies supporting the claim (4)

  • Is it gluten or another wheat component?

    Skodje GI et al.. Gastroenterology 2018 · PMID 29102613 · DOI 10.1053/j.gastro.2017.10.040
    Randomised controlled trialindependent cross-checkabstract checked★ key study

    In people who think they react to gluten, a wheat sugar (fructan) caused more symptoms than gluten.

    Only for self-reported NCGS, not coeliac disease.

    Does the study support the specific claim? Partly · Methodological quality: high · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Gluten vs fructan

    How was the study done?

    Blinded crossover RCT

    How many people, animals or samples were studied?

    59

    What was actually found?

    Fructan, not gluten

    How large was the observed effect?

    GSRS 38.6 vs 33.1

    What do the results mean in everyday life?

    Symptoms may come from wheat carbohydrates

    What are the study's limitations?

    Small

    What does it say about Elawady's specific claim?

    Partly supports 'not gluten'; says nothing about coeliac disease

    Do the results apply to Germany and Europe?

    High

    What can explicitly not be concluded from this study?

    Coeliac disease

    Scientific details →

  • Most people who think they react to gluten do not react in blinded tests

    Molina-Infante J et al.. Clin Gastroenterol Hepatol 2017 · PMID 27523634 · DOI 10.1016/j.cgh.2016.08.007
    Systematic reviewindependent cross-checkabstract checked★ key study

    Only 16% of 231 people with suspected gluten sensitivity reacted specifically to gluten in blinded challenges.

    Supports only the part that self-reported gluten sensitivity is rarely confirmed; does not touch coeliac disease.

    Does the study support the specific claim? Partly · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Check if suspected gluten sensitivity is confirmed under blinding.

    How was the study done?

    Combined data of 10 blinded placebo-controlled trials.

    How many people, animals or samples were studied?

    1312 adults.

    What was actually found?

    Gluten-specific symptoms in 38 of 231 (16%); many had placebo reactions.

    How large was the observed effect?

    16% confirmed; 40% of these also reacted to placebo.

    What do the results mean in everyday life?

    Most self-diagnosed gluten sensitivity is probably not caused by gluten itself.

    What are the study's limitations?

    Heterogeneous trials, short report.

    What does it say about Elawady's specific claim?

    Partly supports the claim for non-coeliac sensitivity; says nothing against coeliac disease.

    Do the results apply to Germany and Europe?

    High.

    What can explicitly not be concluded from this study?

    It cannot show that gluten-related disorders do not exist; coeliac disease is a separate, proven disease.

    Scientific details →

  • Expecting gluten causes more symptoms than gluten itself

    de Graaf MCG et al.. Lancet Gastroenterol Hepatol 2024 · PMID 38040019 · DOI 10.1016/S2468-1253(23)00317-5
    Randomised controlled trialindependent cross-checkabstract checked★ key study

    People with self-reported gluten sensitivity had the most symptoms when they expected and got gluten; gluten given without that expectation caused no extra symptoms.

    Supports only the non-coeliac part; does not concern coeliac disease.

    Does the study support the specific claim? Partly · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Separate the effect of expecting gluten from eating it.

    How was the study done?

    Randomised double-blind trial with four groups.

    How many people, animals or samples were studied?

    83 adults with self-reported gluten sensitivity.

    What was actually found?

    Expectation mattered more than gluten.

    How large was the observed effect?

    Difference up to 9.6 mm on a 100 mm scale.

    What do the results mean in everyday life?

    Belief and anxiety contribute strongly to symptoms.

    What are the study's limitations?

    One-day test, small groups, industry co-funding.

    What does it say about Elawady's specific claim?

    Supports that much non-coeliac gluten sensitivity is not gluten-specific.

    Do the results apply to Germany and Europe?

    High.

    What can explicitly not be concluded from this study?

    Cannot rule out a small gluten effect and says nothing about coeliac disease.

    Scientific details →

  • Five days of gluten did not make the gut leakier in living people

    Iven J et al.. United European Gastroenterol J 2025 · PMID 40138597 · DOI 10.1002/ueg2.70014
    Randomised controlled trialindependent cross-checkabstract checked★ key study

    In 36 adults, eating 16 g of gluten daily for 5 days did not change gut permeability or inflammation markers compared with gluten-free food.

    NCGS symptoms not gluten-specific.

    Does the study support the specific claim? No · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Test gluten effects in vivo.

    How was the study done?

    Randomised crossover.

    How many people, animals or samples were studied?

    36 adults.

    What was actually found?

    No biomarker changes; symptoms not gluten-specific.

    How large was the observed effect?

    No differences.

    What do the results mean in everyday life?

    Lab permeability effects did not show up in people.

    What are the study's limitations?

    Small, single-blind.

    What does it say about Elawady's specific claim?

    Contradicts applying lab findings to everyone.

    Do the results apply to Germany and Europe?

    High.

    What can explicitly not be concluded from this study?

    Cannot rule out long-term subtle effects.

    Scientific details →

Studies contradicting or limiting the claim (6)

  • How common is coeliac disease?

    Singh P et al.. Clin Gastroenterol Hepatol 2018 · PMID 29551598 · DOI 10.1016/j.cgh.2017.06.037
    Meta-analysisindependent cross-checkabstract checked★ key study

    About 1 in 70 have coeliac antibodies and about 1 in 140 biopsy-confirmed disease worldwide.

    Does the study support the specific claim? No · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Prevalence

    How was the study done?

    Meta-analysis

    How many people, animals or samples were studied?

    96 studies

    What was actually found?

    0.7-1.4%

    What do the results mean in everyday life?

    Coeliac disease is real and not rare

    What are the study's limitations?

    Heterogeneity

    What does it say about Elawady's specific claim?

    Contradicts denial of gluten disease

    Do the results apply to Germany and Europe?

    High

    What can explicitly not be concluded from this study?

    Causes of symptoms in non-coeliacs

    Scientific details →

  • European guideline for coeliac disease

    Al-Toma A et al.. United European Gastroenterol J 2019 · PMID 31210940 · DOI 10.1177/2050640619844125
    Guideline / position statementindependent cross-checkfull text, structured risk-of-bias assessment★ key study

    Coeliac disease needs a strict lifelong gluten-free diet; gluten is in wheat, rye and barley (not in uncontaminated rice, maize or oats); non-coeliac gluten sensitivity is recognised after coeliac disease and wheat allergy are excluded.

    Does the study support the specific claim? No · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Guideline

    How was the study done?

    Expert consensus guideline with GRADE grading, based on a PubMed literature review

    What was actually found?

    GFD is treatment

    What do the results mean in everyday life?

    Coeliac patients must avoid gluten

    What are the study's limitations?

    Not based on a systematic review; small expert board; no conflict-of-interest statement in available text

    What does it say about Elawady's specific claim?

    Contradicts denial and reintroduction claims

    Do the results apply to Germany and Europe?

    High

    What can explicitly not be concluded from this study?

    Does not quantify how common NCGS is or whether gluten itself (rather than fructans/ATIs) causes its symptoms

    Scientific details →

  • Some people with wheat sensitivity show signs of gut damage in blood tests

    Uhde M et al.. Gut 2016 · PMID 27459152 · DOI 10.1136/gutjnl-2016-311964
    Case-control studyindependent cross-checkabstract checked★ key study

    People who react to wheat without coeliac disease had higher markers of immune activation and gut-cell damage, which improved off wheat in a subgroup.

    Objective markers in a subgroup of wheat-sensitive people argue against "no such thing as wheat sensitivity".

    Does the study support the specific claim? No · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Look for objective signs in wheat sensitivity.

    How was the study done?

    Blood biomarkers compared between groups.

    How many people, animals or samples were studied?

    Wheat-sensitive people, coeliac patients, healthy controls (numbers not in abstract).

    What was actually found?

    Higher immune and gut-damage markers in the wheat-sensitive group.

    How large was the observed effect?

    Not quantified in abstract.

    What do the results mean in everyday life?

    A subgroup may have a real biological reaction to wheat.

    What are the study's limitations?

    Not blinded; not replicated at scale.

    What does it say about Elawady's specific claim?

    Contradicts the idea that wheat sensitivity does not exist at all.

    Do the results apply to Germany and Europe?

    High.

    What can explicitly not be concluded from this study?

    Cannot show that gluten itself is the trigger or how many people are affected.

    Scientific details →

  • Coeliac disease affects about 1 in 190 Egyptian children

    Abu-Zekry M et al.. J Pediatr Gastroenterol Nutr 2008 · PMID 18664863 · DOI 10.1097/MPG.0b013e31815ce5d1
    Cross-sectional studyindependent cross-checkabstract checked★ key study

    Screening of 1500 Egyptian children found coeliac disease in 0.53%, and much more often in children with diarrhoea or type 1 diabetes.

    Coeliac disease exists in Egypt at about 1 in 190 children.

    Does the study support the specific claim? No · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Measure coeliac disease frequency in Egyptian children.

    How was the study done?

    Blood tests and biopsies.

    How many people, animals or samples were studied?

    1900 children in three groups.

    What was actually found?

    0.53% in the general sample; 4.7% and 6.4% in risk groups.

    How large was the observed effect?

    About 1 in 187.

    What do the results mean in everyday life?

    Coeliac disease is not rare in Egypt.

    What are the study's limitations?

    Single study; children only.

    What does it say about Elawady's specific claim?

    Contradicts the denial of gluten-related disease.

    Do the results apply to Germany and Europe?

    Comparable to Europe.

    What can explicitly not be concluded from this study?

    Does not give adult figures.

    Scientific details →

  • US specialist guideline on coeliac disease (2023)

    Rubio-Tapia A et al.. Am J Gastroenterol 2023 · PMID 36602836 · DOI 10.14309/ajg.0000000000002075
    Guideline / position statementindependent cross-checkabstract checked★ key study

    Coeliac disease is a lifelong immune reaction to gluten from wheat, barley and rye; treatment is a strict gluten-free diet with medical follow-up.

    Coeliac disease is a permanent immune response to gluten.

    Does the study support the specific claim? No · Methodological quality: high · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Guide diagnosis and treatment.

    How was the study done?

    Expert guideline using GRADE.

    How many people, animals or samples were studied?

    not applicable

    What was actually found?

    Antibody test, usually biopsy; strict lifelong gluten-free diet.

    How large was the observed effect?

    not applicable

    What do the results mean in everyday life?

    People with coeliac disease must avoid gluten strictly.

    What are the study's limitations?

    Only abstract read.

    What does it say about Elawady's specific claim?

    Contradicts denial of gluten disorders and gluten reintroduction.

    Do the results apply to Germany and Europe?

    Consistent with European guidance.

    What can explicitly not be concluded from this study?

    Does not address the non-coeliac claims in detail in the abstract.

    Scientific details →

  • UK guideline: test for coeliac disease before cutting out gluten

    National Institute for Health and Care Excellence (NICE). NICE guideline NG20 2015
    Guideline / position statementindependent cross-checkfull text checked★ key study

    People with unexplained iron deficiency, IBS-type symptoms and other signs should be tested, and must keep eating gluten until a specialist confirms the diagnosis.

    Does the study support the specific claim? No · Methodological quality: high · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Guide recognition and testing.

    How was the study done?

    National guideline.

    How many people, animals or samples were studied?

    not applicable

    What was actually found?

    Testing indications; eat gluten for 6 weeks before tests.

    How large was the observed effect?

    not applicable

    What do the results mean in everyday life?

    Stopping bread before testing can hide coeliac disease.

    What are the study's limitations?

    Guideline from 2015.

    What does it say about Elawady's specific claim?

    Contradicts replacing diagnosis by diet change.

    Do the results apply to Germany and Europe?

    UK, consistent with EU.

    What can explicitly not be concluded from this study?

    Does not grade evidence for every recommendation on the page.

    Scientific details →

Studies with mixed or unclear results (1)

  • Gluten and heart disease in people without coeliac disease

    Lebwohl B et al.. BMJ 2017 · PMID 28465308 · DOI 10.1136/bmj.j1892
    Cohort studyindependent cross-checkfull text, structured risk-of-bias assessment★ key study

    Eating more gluten was not linked to more heart disease over 26 years.

    Gluten not harmful for most people.

    Does the study support the specific claim? No · Methodological quality: high · Certainty of evidence: see overall assessment of the claim

    Original publication · Scientific details

    Study explained simply
    What did the researchers want to find out?

    Gluten and CHD

    How was the study done?

    Cohort

    How many people, animals or samples were studied?

    110,017

    What was actually found?

    No association

    How large was the observed effect?

    HR 0.95

    What do the results mean in everyday life?

    Gluten is not a heart risk for non-coeliacs

    What are the study's limitations?

    FFQ estimate

    What does it say about Elawady's specific claim?

    Contradicts general gluten harm

    Do the results apply to Germany and Europe?

    Moderate

    What can explicitly not be concluded from this study?

    Says nothing about gut permeability, intestinal symptoms or whether gluten sensitivity exists; only about heart disease

    Scientific details →

Regional context

Germany / EU

ESsCD guideline (I-GRN-02) recognises coeliac disease, dermatitis herpetiformis, and (less well-defined) NCGS.

Egypt

Coeliac disease occurs in Egypt: about 1 in 187 children in a general-population screening, and 4.7-6.4% in children with diarrhoea or type 1 diabetes (I-GRN-104).

What applies in my country?

General scientific assessment

Mostly false Coeliac disease is real and gluten-driven; only the vaguer 'non-coeliac gluten sensitivity' is genuinely disputed.

The following areas of food safety are relevant to this statement:

  • Pesticides and pesticide residues
  • Mycotoxins (mould toxins)

Cereals and rice

Choose a country to see the checked information for it.

Limits: legal rules describe what is allowed, not what every single food contains. Measurement data come from samples and are meaningful only together with their method details.

Country of residence or purchase Compare with another country

References

  1. Fructan, Rather Than Gluten, Induces Symptoms in Patients With Self-Reported Non-Celiac Gluten Sensitivity.. Skodje GI et al.. Gastroenterology 2018 · PMID 29102613 · DOI 10.1053/j.gastro.2017.10.040
  2. Suspected Nonceliac Gluten Sensitivity Confirmed in Few Patients After Gluten Challenge in Double-Blind, Placebo-Controlled Trials.. Molina-Infante J et al.. Clin Gastroenterol Hepatol 2017 · PMID 27523634 · DOI 10.1016/j.cgh.2016.08.007
  3. The effect of expectancy versus actual gluten intake on gastrointestinal and extra-intestinal symptoms in non-coeliac gluten sensitivity: a randomised, double-blind, placebo-controlled, international, multicentre study.. de Graaf MCG et al.. Lancet Gastroenterol Hepatol 2024 · PMID 38040019 · DOI 10.1016/S2468-1253(23)00317-5
  4. Impact of Acute and Sub-Acute Gluten Exposure on Gastrointestinal Symptoms and Psychological Responses in Non-Coeliac Gluten Sensitivity: A Randomised Crossover Study.. Iven J et al.. United European Gastroenterol J 2025 · PMID 40138597 · DOI 10.1002/ueg2.70014
  5. Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis.. Singh P et al.. Clin Gastroenterol Hepatol 2018 · PMID 29551598 · DOI 10.1016/j.cgh.2017.06.037
  6. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders.. Al-Toma A et al.. United European Gastroenterol J 2019 · PMID 31210940 · DOI 10.1177/2050640619844125
  7. Intestinal cell damage and systemic immune activation in individuals reporting sensitivity to wheat in the absence of coeliac disease.. Uhde M et al.. Gut 2016 · PMID 27459152 · DOI 10.1136/gutjnl-2016-311964
  8. Prevalence of celiac disease in Egyptian children disputes the east-west agriculture-dependent spread of the disease.. Abu-Zekry M et al.. J Pediatr Gastroenterol Nutr 2008 · PMID 18664863 · DOI 10.1097/MPG.0b013e31815ce5d1
  9. American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease.. Rubio-Tapia A et al.. Am J Gastroenterol 2023 · PMID 36602836 · DOI 10.14309/ajg.0000000000002075
  10. Coeliac disease: recognition, assessment and management (NICE guideline NG20) - Recommendations. National Institute for Health and Care Excellence (NICE). NICE guideline NG20 2015
  11. Long term gluten consumption in adults without celiac disease and risk of coronary heart disease: prospective cohort study.. Lebwohl B et al.. BMJ 2017 · PMID 28465308 · DOI 10.1136/bmj.j1892

← Back to overview